在肠道缺血中精准医学:生物标志物的新兴作用
相关实验视频
Updated: Jun 8, 2025
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
539
Chiara Olivero1, Federico Carbone1,2, Luca Liberale3,4
1First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy.
Internal and emergency medicine
|November 7, 2024
概括
早期发现肠道缺血症 (IIs) 是至关重要的. 新的循环生物标志物如FABPs,SDF-1,D-乳酸盐,α-氨酸S转移酶和SM22在II管理中显示出改善诊断和患者分层的希望.
科学领域:
- 胃肠病学 胃肠病学
- 生物标志物发现发现
- 临床诊断 临床诊断 临床诊断
背景情况:
- 肠道缺血症 (IIs) 是一种关键的胃肠道疾病,涉及肠道血流减少,导致炎症和损伤.
- 早期诊断和管理对于预防严重并发症和改善患者结果至关重要.
- 循环生物标志物为增强患者分层和指导IIs治疗决策提供了潜在的途径.
研究的目的:
- 审查肠道缺血症循环生物标志物研究的当前进展.
- 突出特定生物标志物的诊断和预后潜力,包括FABP,SDF-1,D-乳酸盐,α-氨酸S转移酶和SM22.
- 讨论将这些生物标志物和治疗策略纳入临床实践,以改善II管理.
主要方法:
- 关于肠道缺血生物标志物的最近研究的文献综述.
- 对IIs患者特定蛋白质 (FABPs,SDF-1,D-乳酸盐,α-氨酸S转移酶,SM22) 的表达水平的数据分析.
- 评估目前和新兴的治疗策略对IIs的疗效.
主要成果:
- 脂肪酸结合蛋白 (I-FABP,L-FABP) 的血水平升高表明由于肠细胞膜损伤导致的早期肠道缺血症.
- 在IIs患者中观察到肌肉细胞衍生因子-1 (SDF-1) 和D-乳酸盐水平的增加.
- 阿尔法-氨酸S转移酶和SM22在特定类型的肠道缺血中显示出显著升高的水平,有助于区分.
结论:
- 特定的循环生物标志物显示出早期检测和分化肠道缺血的巨大潜力.
- 将这些生物标志物纳入临床实践可以增强患者分层,并指导个性化治疗决策.
- 进一步的研究和临床验证至关重要,以优化这些生物标志物的使用,以改善肠道缺血病的管理和预后.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
319
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
319
01:29Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103